HIV Medicine

Article	Citations
Perspectives of people with HIV and HIV clinicians on characteristics of antiretroviral treatment and HIV‐related symptoms	81
Subclinical atherosclerosis as detected by carotid ultrasound and associations with cardiac and HIV‐specific risk factors; the Archi‐Prevaleat project	80
Issue Information	75
	74
Issue Information	48
Disparities in HIV continuum of care in the paediatric population: A real‐life study in Brazil	41
Telemedicine in HIV health care during the COVID‐19 pandemic: An implementation research study in Buenos Aires, Argentina	41
	37
IgG seroprevalence of COVID‐19 among people living with HIV or at high risk of HIV in south‐west Germany: A seroprevalence study	37
Loneliness and social isolation in people with HIV aged ≥50 years. The No One Alone (NOA)‐GeSIDA study conducted by the GeSIDA 12021 study group	35
Late diagnosis of HIV infection in Warsaw: Estimating the scale of the problem and demographic trends	32
The characteristics of men who have sex with men (MSM) using post‐exposure prophylaxis for sexual exposure (PEPSE) in the pre‐exposure prophylaxis (PrEP) era	28
Areas with high HIV prevalence: A spatial analysis of nationwide claims data in Germany	28
	27
The data‐collection on adverse effects of anti‐HIV drugs (D:A:D) model for predicting cardiovascular events: External validation in a diverse cohort of people living with HIV	25
Issue Information	25
Fostemsavir and ethinyl estradiol drug interaction: Clinical recommendations for co‐administration	25
Reflections on a specialist HIV menopause service	24
Clinical characteristics of monkeypox virus infections among men with and without HIV: A large outbreak cohort in Germany	24
Effect of an opt‐out point‐of‐care HIV‐1 nucleic acid testing intervention to detect acute and prevalent HIV infection in symptomatic adult outpatients and reduce HIV transmission in Kenya: a randomiz	23
HIV cure: Are we going to make history?	21
	19
Are there additional adverse effects of testosterone use among men living with HIV?—Data from the PUSH! study	19
Potentially inappropriate prescriptions and potential prescription omissions in older people living with HIV	19
Prescribing patterns of antiretroviral treatments during pregnancy for women living with HIV in Canada 2004–2020: A surveillance study	19

Issue Information	16
The value of herpes zoster prevention in people aging with HIV: A narrative review	16
Efficacy and safety of dolutegravir/rilpivirine in real‐world clinical practice. GeSIDA study 1119	15
Development of the HIV360 international core set of outcome measures for adults living with HIV: A consensus process	14
The effect of HIV and mpox co‐infection on clinical outcomes: Systematic review and meta‐analysis	14
Immune reconstitution inflammatory syndrome‐associated Graves disease in HIV‐infected patients: clinical characteristics and response to radioactive iodine therapy	14
Influence of physical activity on endothelial function in people living with HIV	14
Efficacy of an electronic reminder for HIV screening in primary healthcare based on indicator conditions in Catalonia (Spain)	13
Using an automated decision support tool to improve HIV prescribing: A feasibility study	13
Efficacy, durability, and tolerability of dolutegravir/lamivudine and dolutegravir/rilpivirine for the treatment of HIV in a real‐world setting in Belgium	12
Exploring implementation considerations forgeriatric‐HIVclinics: A secondary analysis from a scoping review onHIVmodels of geriatric care	12
British HIV Association guidelines on the management of opportunistic infection in people living with HIV: The clinical management of non‐tuberculous mycobacteria 2024	12
Special issue on Women and HIV to mark International Women’s Day	12
Assessment of targeted intervention programme under the National AIDS Control Program among men who have sex with men in India	12
Associations between HIV infection and frailty status and its individual components: Are frailty components disproportionally affected?	12
The first AI‐based Chatbot to promote HIV self‐management: A mixed methods usability study	12
Compassionate use of long‐acting cabotegravir plus rilpivirine for people living with HIV‐1 in need of parenteral antiretroviral therapy	12
	12
No increased risk of tuberculosis‐related immune reconstitution inflammatory syndrome with integrase inhibitor‐based antiretroviral therapy in people withHIV with profound immunosuppression	12
Exploring the cascade of mental healthcare among people with HIV experiencing depressive symptoms in the UK and Ireland: The POPPY study	12
	12
	12
Issue Information	11
Increasing HIV early diagnosis by implementing an automated screening strategy in emergency departments	11
Low frequency of cytomegalovirus (CMV) disease despite high prevalence of CMV viraemia in patients with advanced HIV infection: a clinical and immunological 48‐week follow‐up study	11
HIV‐associated thrombotic thrombocytopenic purpura (HIV‐TTP): A practical guide and review of the literature	11
Microbial translocation is associated with advanced liver fibrosis among people with HIV	11
Access to care and impact on HIV treatment interruptions during the COVID‐19 pandemic among people living with HIV in British Columbia	11
Issue Information	10
“Editorial comment on: Increased incidence of diabetes in people living with HIV treated with first‐line integrase strand transfer inhibitors: A French multicentre retrospective study”	10
Predictors of poor health‐related quality of life among people living with HIV aged ≥60 years in the PISCIS cohort: Findings from the Vive+ project	10
Viral rebound on antiretroviral therapy in France according to region of origin, sex, and HIV acquisition group. Results from the French Hospital Database on HIV (ANRS CO4	10
Association between markers of hepatitis B virus infection and risk of virological rebound in people with HIV receiving antiretroviral therapy	10
	10
AI in medicine: No longer the future, but the present	10
Urinary biomarkers of early renal injury in antiretroviral‐naïve HIV‐positive persons in Shanghai, China: comparison with the general population	10
	10
Oral Abstracts	9
The role of HIV as a risk modifier for coronary endothelial function in young adults	9
Blood‐borne virus testing in emergency departments – a systematic review of seroprevalence, feasibility, acceptability and linkage to care	9
Author Index	9
Clinical significance and management of low‐level HIV viremia in the era of integrase strand transfer inhibitors	9
An updated systematic review of HIV‐associated cryptococcal meningitis treatment strategies	9
De‐simplifying antiretroviral therapy from a single‐tablet to a two‐tablet regimen: Acceptance, patient‐reported outcomes, and cost savings in a multicentre study	9
Immunostimulatory effects of Hsp70 fragments and Hsp27 in design of novel HIV‐1 vaccine formulations	9
Characterization of HIV‐1 drug resistance among patients with failure of second‐line combined antiretroviral therapy in central Ethiopia	9
	9
Frequent hepatitis B surface antigen (HBsAg) clearance during tenofovir therapy in persons with HIV/hepatitis B virus coinfection	9
HCV incidence in people with HIV in southwest China: A retrospective cohort study (2004–2023)	9
Mortality and AIDS‐defining events among young people following transition from paediatric to adult HIV care in the UK	9

Prevalence, progression, and management of advanced chronic kidney disease in a cohort of people living with HIV	8
Issue Information	8
Burden of liver steatosis and liver fibrosis in a large cohort of people living with HIV	8
Virtual care pathways for people living with HIV: A mixed‐methods systematic review	8
Frailty and frailty screening: A qualitative study to elicit perspectives of people living with HIV and their healthcare professionals	8
Increased incidence of diabetes in people living with HIV treated with first‐line integrase strand transfer inhibitors: A French multicentre retrospective study	8
Biomarkers of inflammation and coagulation predict non‐AIDS‐defining events in a prospective cohort of virologically suppressed people living with HIV	8
Author Index	8
Issue Information	8
Change in metabolic parameters after switching from triple regimens with tenofovir alafenamide to dolutegravir‐based dual therapy. Bi‐lipid study	8
Pneumocystis jirovecii pneumonia–Immune reconstitution inflammatory syndrome: A review of published cases	8
Study of natural product adverse events in adult HIV‐infected patients in Canada	7
Short report: Characterizing HIV care among a clinical sample of transgender women living with HIV	7
Women with HIV transitioning through menopause: Insights from the Swiss HIV Cohort Study (SHCS)	7
Issue Information	7
Issue Information	7
Impact of switching to raltegravir and/or adding losartan in lymphoid tissue fibrosis and inflammation in people living with HIV. A randomized clinical trial	7
Themed Posters	7
Scars are frequently found as late sequelae in individuals affected by the 2022 mpox outbreak	7
Availability and stock‐outs of paediatric antiretroviral treatment formulations at health facilities in Kenya and Uganda	7
Incidence and predictors of attrition from HIV treatment among adults living with HIV in high‐caseload facilities following implementation of universal test and treat strategy in	7
Late diagnosis of HIV: An updated consensus definition	7
‘We want it all’:ARTpreferences assessed byDesirability ofOutcomeRanking	7
Managing cardiovascular risk in people living with HIV in Asia – where are we now?	7
Point‐of‐care nucleic acid testing – a step forward in controlling the HIV epidemic: A review	7
“Real world” efficacy of bulevirtide in HBV/HDV‐related cirrhosis including people living with HIV: Results from the compassionate use programme at INMI Spa	7
Immune response to ART initiation in advanced HIV infection	7
British HIV Association guidelines for the management of HIV‐2 2021	7
Intergenerational sex and early sexual debut are associated with HIV infection among transgender women in Paraguay	7
Anticholinergic medications associated with falls and frailty in people with HIV	7
Spatial and temporal trends in HIV/AIDS burden among South Asian countries from 1990 to 2021: A systematic examination of the Global Burden of Disease study 2021	7
Lipid nanoparticles in antiretroviral therapy: A nanotechnology breakthrough for HIV/AIDS treatment	7
Positive Outcomes: Validity, reliability and responsiveness of a novel person‐centred outcome measure for people with HIV	6
Effect of HIV infection on pre‐ and post‐liver transplant mortality in patients with organ failure	6
Multicentre service evaluation of injectable cabotegravir and rilpivirine delivery and outcomes across 12 UK clinics (SHARE LAI‐net)	6
Sleep deficiency among people living with human immunodeficiency virus: A growing challenge	6
Facilitators and barriers of women's participation in HIV clinical research in Switzerland: A qualitative study	6
Issue Information	6
SARS‐CoV‐2 vaccine immunogenicity for people living with HIV: A systematic review and meta‐analysis	6
Issue Information	6
Quality of life among people living with HIV aged 50 years and over in Australia: Identifying opportunities to support better ageing	6
Implementation of frailty screening for older people living with HIV in Brighton, UK	6
Weight changes, metabolic syndrome and all‐cause mortality among Asian adults living with HIV	6
Prevalence of, risk factors for, and target organ damage from metabolic syndrome among people living with HIV on ART: A cross‐sectional analysis in Chongqing, China	6
	6
CROI 2024 BHIVA working group summary	6
High mortality among patients hospitalized for drug‐resistant tuberculosis with acquired second‐line drug resistance and high HIV prevalence	6
Potential drug–drug interactions between antiretroviral drugs and comedications, including dietary supplements, among people living with HIV: A clinical survey	6
Clinical outcomes of HIV–syphilis coinfection among patients with no neurological symptoms: a retrospective cohort study	6
Assessing weight change in adolescents and young adults with perinatally acquired HIV and integrase inhibitor use	6
One for all, all for one: neuro‐HIV multidisciplinary platform for the assessment and management of neurocognitive complaints in people living with HIV	6
Issue Information	5
Efficacy of dolutegravir + lamivudine q.d. with food in people with TB/HIV using a rifampicin‐based regimen: A retrospective observational case series	5
What are the predictors of change in multimorbidity among people with HIV? A longitudinal observational cohort study	5
Trends in preterm birth in women living with HIV in Switzerland over the last three decades: A multicentric, prospective, cohort study	5
Tolerability of four‐drug antiretroviral combination therapy in primary HIV‐1 infection	5
Issue Information	5
Anal cytological abnormalities and human papillomavirus infection in women living with HIV: A systematic review and meta‐analysis	5
Efficacy and safety of bictegravir/emtricitabine/tenofovir alafenamide in Black and Hispanic/Latine adults with HIV‐1 initiating first‐line therapy: 5‐year follow‐up from two phase III stud	5
Sexually transmitted and blood‐borne infection risk reduction with methadone and buprenorphine/naloxone among people with prescription‐type opioid use disorder: Findings from a Canadian pragmatic rand	5
Low‐level HIV viraemia during antiretroviral therapy: Longitudinal patterns and predictors of viral suppression	5
	5
Frailty and sarcopenia among Turkish people aged 40 and above living with HIV	5
	5
Optimizing statin prescriptions for people living with HIV: Evidence for improved communication and shared care between primary care and specialist HIV services	5
Longitudinal analysis of new‐onset non‐AIDS‐defining diseases among people living with HIV: A real‐world observational study	5
Impact of HBV serological status on HIV virological efficacy of two‐drug antiretroviral regimens: A retrospective observational study on virologically suppressed people with	5
Correction to ‘Abstracts of the 19th European AIDS Conference (#EACS2023), October 18–21, 2023, Warsaw, Poland’	5
Viral suppression after transition from nonnucleoside reverse transcriptase inhibitor‐ to dolutegravir‐based antiretroviral therapy: A prospective cohort study in Lesotho (DO‐REAL study)	5
No overall impact on rate of weight gain with integrase inhibitor‐containing regimens in antiretroviral‐naïve adults	5
Issue Information	5
Impact of the COVID‐19 pandemic on the HIV care continuum and associated factors in middle‐income countries: A mixed‐methods systematic review	5
Predictors of knowledge of and access to biomedical prevention among MSM and transgender men in Latin America: Results from the Latin American internet survey	5
	5
Factors influencing the quality of life and social skills of children living with HIV: A case–control study	5
Cost of non‐communicable diseases in people living with HIV in the Central Denmark Region	5
Long‐term outcomes for children and adolescents with Kaposi sarcoma	5
Use of antiretroviral therapy in pregnancy and association with birth outcome among women living with HIV in Denmark: A nationwide, population‐based cohort study	4
HIV treatment strategies across Central, Eastern and Southeastern Europe: New times, old problems	4
Issue Information	4

Hepatitis C coinfection and extrahepatic cancer incidence among people living with HIV	4
Potential drug–drug interactions in males living with HIV who use drugs to treat lower urinary tract symptoms	4
	4
Efficacy and safety of dolutegravir/lamivudine in virologically suppressed female participants: week 48 data from the pooled TANGO and SALSA studies	4
	4
Cardiac adiposity as a modulator of cardiovascular disease in HIV	4
HIV and fracture: Risk, assessment and intervention	4
Erratum	4
Frailty in people 50 years or older living with HIV: A sex perspective	4
Early HIV treatment and survival over six years of observation in the ANRS 12249 Treatment as Prevention Trial	4
	4
BMI as a predictor of high fasting blood glucose among people living with HIV in the Asia‐Pacific region	4
	4
Issue Information	4
Efficacy and durability of two‐ vs. three‐drug integrase inhibitor‐based regimens in virologically suppressed HIV‐infected patients: Data from real‐life ODOACRE cohort	4
Abstracts	4
Switch to a raltegravir‐based antiretroviral regimen in people with HIV and non‐alcoholic fatty liver disease: A randomized controlled trial	4
	4
PrEP for women in Europe: a systematic literature review	4
Bictegravir/emtricitabine/tenofovir alafenamide in paediatrics: Real‐life experience from a French cohort (2019–2023)	4
Issue Information	4
Immunological and virological response to initial antiretroviral therapy among older people living with HIV in the Canadian Observational Cohort (CANOC)	4
Asian participants' experience in phase 3/3b studies of long‐acting cabotegravir and rilpivirine: Efficacy, safety, pharmacokinetic, and virological outcomes through week 96	4
	4
Twelve‐month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV: Real‐world insights from BICSTaR cohorts	4
Direct, indirect and total effect of HIV coinfection on the risk of non‐liver‐related cancer in hepatitis C virus‐infected patients treated by direct‐acting antivirals: a mediation analysis	4
Late diagnosis of HIV in 2022: Why so little change?	4